IGEM Therapeutics is an immuno-oncology company focused on the development of IgE antibody drugs to fight cancer. Founded by Sophia Karagiannis, IGEM Therapeutics is backed by investors that include AlbionVC, ALSA Holdings, and Epidarex Capital.